 |
ImmunoLogik
Last updated: July 31, 2024
Christian Setz, CEO
Germany | Funding: €301.4K (+)
Website: https://immunologik.de/
ImmunoLogik has identified an active agent that helps patients who have developed a resistance against standard HIV treatment therapies.
Website: https://immunologik.de/
ImmunoLogik has identified an active agent that helps patients who have developed a resistance against standard HIV treatment therapies.
